Champions Oncology, Inc. (CSBR) stock
CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/30245% above fair value
$4.59−0.09 (-1.89%)
Close on Nov 17, 2026Market cap $63.91MP/E –Yield –
Champions Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Champions Oncology's enterprise value was $62.74M on Nov 11, 2026, against $79.88M a year earlier. Over the last 5 years it ranged from $42.86M to $147.80M, with a median of $77.25M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $62.74M | -28.3% |
| 2025 | Dec 31, 2025 | $87.50M | -23.7% |
| 2024 | Dec 31, 2024 | $114.65M | +61.7% |
| 2023 | Dec 29, 2023 | $70.88M | +40.9% |
| 2022 | Dec 30, 2022 | $50.32M | -53.4% |
| 2021 | Dec 31, 2021 | $108.05M | -20.4% |
| 2020 | Dec 31, 2020 | $135.69M | +44.3% |
| 2019 | Dec 31, 2019 | $94.01M | +7.2% |
| 2018 | Dec 31, 2018 | $87.66M | +108.8% |
| 2017 | Dec 29, 2017 | $41.97M | +79.2% |
| 2016 | Dec 30, 2016 | $23.42M | -13.0% |
| 2015 | Dec 31, 2015 | $26.91M | -18.1% |
| 2014 | Dec 31, 2014 | $32.87M | -6.9% |
| 2013 | Dec 31, 2013 | $35.31M | +331.1% |
| 2012 | Dec 31, 2012 | $8.19M | -56.3% |
| 2011 | Dec 30, 2011 | $18.73M | – |
See a number that looks wrong?